Preventive Healthcare Technologies And Services Market (2026 - 2033)

Preventive Healthcare Technologies And Services Market Summary

The global preventive healthcare technologies and services market size was valued at USD 382.7 billion in 2025 and is projected to grow from USD 415.9 billion in 2026 to USD 790.6 billion in 2033, at a CAGR of 9.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. The growth of this market is attributed to the increasing prevalence of lifestyle-associated and other chronic diseases.

According to a report by the National Institutes of Health (NIH), 35.66% of the U.S. adults aged 50 and over will have at least one chronic condition by 2035. Preventive healthcare has been gaining popularity in the past decade, with the growing number of awareness programs by the government. The Patient Protection and Affordable Care Act, or Obamacare, has mandated that insurance providers cover preventive healthcare at no additional cost. The private insurance companies have also started shifting their focus to this market due to its huge potential.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

From the customers’ perspective, preventive healthcare gives people a better-quality and stress-free life. The investment in these insurance policies or the average spending on these services is far less compared to the average spending on treating any disease in the hospital. According to the U.S. Census Bureau, approximately 310 million the U.S. citizens (approximately 92.0% of the population) had health insurance coverage for some or all of 2024, reflecting sustained access to healthcare services and preventive care programs. Along with affordability, the easy availability of diagnostic devices capable of early detection of asymptomatic diseases is expected to fuel growth during the forecast period

Though the target population of these services and technologies includes everyone from all age groups, a major part includes geriatrics, which are more prone to chronic conditions and acute cardiovascular diseases. The geriatric population is on the rise and is expected to grow throughout the forecast period, which is anticipated to impact growth positively. According to the World Health Organization (WHO), the population aged 60 and over is expected to double between 2020 and 2050, reaching 2.1 billion by 2050. Meanwhile, the number of people aged 80 and over is projected to reach 426 billion by 2050.

Analyst Perspective

The preventive healthcare technologies and services market is a high-growth sector driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and growing emphasis on early disease detection and wellness management. Some of the major advancements in the diagnostics tools, the digital health sector, the wearables industry, and predictive analytics will help improve the quality of preventive care offered and increase its availability. Furthermore, the rise of digital health ecosystems and personalized medicine provides many business prospects within the preventive healthcare technologies and services market. The healthcare sector relies on AI-enabled analytics, sensors, and cloud-based monitoring platforms to offer healthcare services proactively.

Changing consumer behavior and shifting towards wellness monitoring and personalized healthcare solutions is also promoting market growth. However, technologies used in preventive health care depend largely on patient data gathering, cloud connectivity, and digital communications, hence increase the risk of cyber-attacks and compromising patient data privacy. The healthcare industry needs to embrace robust data protection systems to prevent data breaches, which are mainly affecting market growth.

Type Insights

Based on type, the market is segmented into early detection and screening technologies, chronic disease management technologies, vaccines, and advanced technologies to reduce errors. The early detection and screening technologies segment dominated the market with the largest revenue share of more than 20.0% in 2025. The advantages associated with personalized medicine technologies, such as high accuracy and detection of possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.

The chronic diseases segment is expected to grow at a lucrative CAGR over the forecast period, owing to user-friendly devices such as blood pressure monitors, glucose monitors, and asthma monitors, which can be used without the help of any professionals or any training.

The vaccines segment held a significant share in 2025. Vaccination is the best prophylactic measure as it enables the development of antibodies by the body itself and does not require any screening to detect a particular disease. Vaccines against Influenza and Bacteria (Tetanus, Diphtheria, Pertussis) exist. The demand for vaccines will continue to grow as R&D activities increase and new vaccination campaigns are launched to speed up the vaccination process. This will further expand the global preventive healthcare technologies and services market. Ongoing clinical trials for the vaccines designed to slow or cease degenerative disorders, such as Parkinson’s and Alzheimer’s, have been witnessing positive results.

Regional Insights

North America dominated the market with the largest revenue share of over 40.0% in 2025. The presence of well-established healthcare infrastructure, the higher adoption rate of advanced technology, the increase in the incidence of chronic disease, and the high awareness regarding preventive healthcare measures are the factors attributed to the region's domination. For instance, according to the Centers for Disease Control and Prevention (CDC), six in ten adults in the U.S. have at least one chronic disease, while four in ten have two or more chronic conditions. Moreover, ongoing investments in preventive healthcare technologies are expected to further boost the market. For instance, in April 2025, Teladoc Health introduced its next generation cardiometabolic health program, integrating obesity management, hypertension care, diabetes prevention, and personalized health coaching into a comprehensive digital platform. The launch reflects the growing emphasis on preventive healthcare solutions and technology-enabled chronic disease management across the region.

To learn more about this report, Download Free Sample Report

Asia Pacific Preventive Healthcare Technologies And Services Market Trends

Asia Pacific region is expected to grow at the fastest CAGR of over 14.0% over the forecast period, owing to increased government initiatives, adoption of advanced technologies, rising per capita income, and the presence of a large number of players engaged in the development of advanced technology for preventive healthcare in countries such as Japan and India, which is expected to boost the growth of the market in the region. The presence of major companies, such as Serum Institute of India Private Limited and Biocon, has increased the entry barrier for new entrants in the region.

Key Preventive Healthcare Technologies And Services Market Companies Insights

The overall market is consolidated, with a few key players capturing most of the revenue. Early detection and screening technology is dominated by companies such as Novx Systems, Inc., and Dilon Technologies, Inc. Major vaccine segment players include Merck & Co., Inc., Pfizer, Inc., and GlaxoSmithKline plc. These companies are primarily focusing on launching new products and get approval from concerned authorities to introduce their offering sin the market. For instance, in January 2026, the European Commission approved GlaxoSmithKline plc’s respiratory syncytial virus (RSV) vaccine for use in all adults. Earlier, the vaccine was only authorized for people aged 60 and above, as well as for those who are aged 50 and over and are at increased risk of RSV. Also, in addition, in June 2024, Merck & Co., Inc. received U.S. FDA approval for Capvaxive (pneumococcal 21-valent conjugate vaccine) for adults. Companies are also actively undertaking strategies such as partnerships and collaboration to expand their capabilities and offerings. For instance, Merck & Co., Inc. partnered with Protillion for AI-driven protein engineering and drug discovery. 

Key Preventive Healthcare Technologies And Services Market Companies

The following key companies have been profiled for this study on the preventive healthcare technologies and services market:

• Myriad Genetics, Inc.

• Quest Diagnostics Incorporated

• Medtronic

• Abbott

• Merck & Co., Inc.

• GSK plc

• Omnicell

• MCKESSON CORPORATION

Recent Developments

• In April 2025, GE HealthCare entered a strategic collaboration with FPT Software to accelerate the development of AI-enabled healthcare solutions, focusing on improving early disease detection, diagnostic accuracy, and preventive care delivery across global healthcare systems. This partnership highlights the increasing integration of artificial intelligence and digital health technologies in strengthening preventive healthcare infrastructure.
• In February 2026, Siemens Healthineers partnered with Mayo Clinic to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for neurodegenerative diseases, prostate cancer, and other.

Global Preventive Healthcare Technologies And Services Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preventive healthcare technologies and services market based on type and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Early Detection & Screening Technologies
    • Automated Screening Market
    • Personalized Medicine Market
    • Other Advanced Screening Technologies
  • Chronic Disease Management Technologies
    • Blood Pressure Monitors
    • Asthma Monitors
    • Cardiovascular Monitors
    • Glucose Monitors
  • Vaccines
    • Infectious Diseases
    • Cancer
    • Autism
    • Allergy
    • Others
  • Advanced Technologies to Reduce Errors
    • Electronic Prescribing
    • Clinical Decision Support System
    • Smart Infusion Pumps
    • Computerized Provider Order Entry System
    • Smart Packaging
    • Automated Prescription Formulation & Dispensing
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait